Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FTSE 100 Live 06 February: Index higher ahead of interest rates decision, AstraZeneca results
The FTSE 100 index is set to make a swift return towards record territory after IG Index futures forecast a rise of 58 points at the opening bell. The gain follows yesterday’s advance of 53 points to 8623 as the top flight clawed back earlier losses caused by America’s 25% trade tariffs on Mexico and Canada. The record high is 8692.
FTSE 100 LIVE: Stocks push higher as Bank of England expected to cut interest rates
The FTSE 100 ( ^FTSE) and European stocks were higher on Thursday as the Bank of England is likely to make its first interest rate cut in three months. Analysts predict the benchmark rate will be cut from 4.75% to 4.5% at noon, with with only the hawkish Catherine Mann opposing a reduction in borrowing costs for the first time this cycle.
Britain's FTSE 100 dips marginally ahead of BoE rate decision
British stocks were set to fall for the third straight session on Wednesday, as a stronger pound put pressure on the export-heavy index, while caution prevailed ahead of the Bank of England's rate decision.
FTSE 100 hits record high ahead of expected interest rate cut
UK stocks rallied to hit a fresh record ahead of the rate decision. The FTSE 100 is up 1.1 per cent — touching a fresh high — helped by weakness in the pound. The mid-cap FTSE 250 rose 0.7 per cent. Most sectors in the FTSE 100 were up,
LIVE
FTSE 100 Live: Pound Falls, UK Stocks Rally Ahead of Expected BOE Rate Cut
UK stocks have opened in positive territory, with the FTSE 100 up 0.7% and the FTSE 250 up 0.4%. The pound has weakened more against the dollar, now down 0.3%, and is about flat against the euro. Gilt yields aren’t moving much.
17h
on MSN
GSK, gold miners shares push Britain's FTSE 100 higher
UK's FTSE 100 firmed on Wednesday after two straight days of losses, buoyed by gains in shares of heavyweight GSK and gold ...
2d
on MSN
FTSE 100 Live 04 February: Index seen lower amid trade turbulence, Guinness owner Diageo post results
Drinks giant Diageo today reported a return to sales growth but warned that US tariffs could impact the company’s “building ...
18h
FTSE 100 higher while gold hits new highs
Further gains propel the ounce troy of Gold to all-time highs near the $2,880 mark on the back of the weak US Dollar, ...
3d
FTSE 100 tumbles after Trump announces tariffs and hasn't ruled out UK goods tax
US President Donald Trump warned the European Union and the UK they would be hit with tariffs unless they 'work it out' ...
1d
on MSN
FTSE 100 Live 05 February: GSK shares surge on new guidance, gold at record price
An improved long-term sales target today revitalised GSK shares after their dismal 2024. Mining stocks also rallied today after the price of gold set another record high. GSK dominated a steady FTSE ...
5d
FTSE 100 reaches another record high as January is the best month in more than two years
Tech stock sell off over AI investment fears and the expectation of cheaper borrowing through more interest rate cuts are ...
1d
FTSE 100 lower, US indices up, buoyed by tech gains and tariff extensions
Stocks trended lower on Tuesday for a second day, as investors weigh the most recent movements in US president Donald Trump's ...
12d
FTSE 100 slides as stronger sterling hits export-focused firms; Burberry soars
Britain's FTSE 100 fell on Friday, as a jump in sterling hurt export-oriented firms, while Burberry soared after a strong U.S ...
Investing
6d
FTSE 100 set for best month in two years after breaking record again
The FTSE 100 pushed further into record territory as trading got underway on Friday, climbing 25 points to a new all-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Donald Trump
United States
GSK
Diageo
GlaxoSmithKline
Feedback